drugset / Trial / NCT00717652

Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma

NCT00717652

Phase 2/3 Suspended 110 enrolled Azidus Brasil
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is evaluating the clinical activity of the association (tretinoin + arbutin + triamcinolone) in the treatment of epidermal melasma.

Timeline

Start
2008-07
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoncinolone Unknown Topical
Comparator Hydroquinone Small molecule Topical
Subject Triamcinolone Other / unclassified Topical
Subject arbutin Small molecule Topical
Background Tretinoin Small molecule Topical